Literature DB >> 7093098

Labetalol: the nineteen-eighties.

J I Robertson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7093098      PMCID： PMC1401842          DOI： 10.1111/j.1365-2125.1982.tb01903.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  25 in total

Review 1.  Labetalol: a review of its pharmacology and therapeutic use in hypertension.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-04       Impact factor: 9.546

2.  Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results.

Authors:  C Wilhelmsson; J A Vedin; L Wilhelmsen; G Tibblin; L Werkö
Journal:  Lancet       Date:  1974-11-16       Impact factor: 79.321

Review 3.  The use of beta blockers for the reduction of mortality after myocardial infarction.

Authors:  J R Hampton
Journal:  Eur Heart J       Date:  1981-08       Impact factor: 29.983

4.  Beta-adrenergic blockade after myocardial infarction.

Authors:  P Sleight
Journal:  N Engl J Med       Date:  1981-04-02       Impact factor: 91.245

5.  Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Preliminary results.

Authors:  M P Andersen; P Bechsgaard; J Frederiksen; D A Hansen; H J Jürgensen; B Nielsen; F Pedersen; O Pedersen-Bjergaard; S L Rasmussen
Journal:  Lancet       Date:  1979-10-27       Impact factor: 79.321

6.  Alpha adrenergic contributions to dysrhythmia during myocardial ischemia and reperfusion in cats.

Authors:  D J Sheridan; P A Penkoske; B E Sobel; P B Corr
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

7.  Alternatives to beta-blockade in therapy of hypertension with angina pectoris: role of nifedipine or of labetalol.

Authors:  L H Opie; D White; J Lee; W F Lubbe
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

8.  Role of labetalol in acute myocardial infarction.

Authors:  A D Timmis; M B Fowler; N S Jaggarao; R Vincent; D A Chamberlain
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

9.  A study of labetalol in patients of European, West Indian and West African origin.

Authors:  K Jennings; V Parsons
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

10.  Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol.

Authors:  E A Rosei; J J Brown; A F Lever; A S Robertson; J I Robertson; P M Trust
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335
View more
  2 in total

1.  Alpha-blockers and converting enzyme inhibitors.

Authors:  P C Rubin; J L Reid
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-09

Review 2.  Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.

Authors:  P Lund-Johansen
Journal:  Drugs       Date:  1984       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.